Targeting Neuroinflammation to Treat Alzheimer’s Disease
2017 · CNS Drugs · 224 citations
https://doi.org/10.1007/s40263-017-0483-3
P
Patrick Weydt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
227
Papers
9.2K
Citations
49
h-index
102
i10-index
Patrick Weydt is an academic researcher from University of Bonn. The author has contributed to research in topics: Amyotrophic Lateral Sclerosis Research & Neurogenetic and Muscular Disorders Research & Genetic Neurodegenerative Diseases. The author has an h-index of 49, co-authored 193 publications.
ORCID: 0000-0003-2344-5662Papers by this author
worksEffects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program
2024 · EClinicalMedicine · 94 citations
https://doi.org/10.1016/j.eclinm.2024.102495
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age
2013 · Neurobiology of Disease · 54 citations
https://doi.org/10.1016/j.nbd.2013.05.015
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
2023 · EBioMedicine · 44 citations
https://doi.org/10.1016/j.ebiom.2023.104521
Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings
2024 · Nature Genetics · 36 citations
https://doi.org/10.1038/s41588-024-01836-1
Clinical and patient‐reported outcomes and neurofilament response during tofersen treatment in <i>SOD1</i>‐related <scp>ALS</scp>—A multicenter observational study over 18 months
2024 · Muscle & Nerve · 29 citations
https://doi.org/10.1002/mus.28182
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat